VAALCO Energy, Inc. Announces Fourth Quarter and Full Year 2015 Results
Mar 16, 2016 20:44 pm UTC| Business
HOUSTON, March 16, 2016 -- VAALCO Energy, Inc. (NYSE:EGY) today reported results for the fourth quarter and full year 2015. 2015 and Recent Highlights: Received $19 million payment from VAALCO’s Angola Block 5...
Zipcar Transforms Vehicle into Smallest Concert Venue in ATX
Mar 16, 2016 20:41 pm UTC| Business
AUSTIN, Texas, March 16, 2016 -- WHAT:Zipcar, the world’s leading...
MacroGenics Announces Five Posters at AACR Annual Meeting 2016
Mar 16, 2016 20:31 pm UTC| Business
ROCKVILLE, Maryland, March 16, 2016 -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for...
OncoMed to Present Data at the American Association of Cancer Research Annual Meeting 2016
Mar 16, 2016 20:30 pm UTC| Business
REDWOOD CITY, Calif., March 16, 2016 -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED) will present new data related to its clinical and preclinical anti-cancer stem cell and immuno-oncology therapeutic candidates in a...
ABM to Save South Carolina’s Anderson County School District 2 and 3 over $6 Million
Mar 16, 2016 20:30 pm UTC| Business
NEW YORK, March 16, 2016 -- ABM(NYSE:ABM), a leading provider of facility solutions, announced its ABM Building Solutions business has been selected by Anderson County School District 2 and District 3 in South Carolina...
Mar 16, 2016 20:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 16, 2016 -- CytomX Therapeutics (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today announced that...
Five Prime Therapeutics to Present New Pre-Clinical Data on FPA144 at the 2016 AACR Annual Meeting
Mar 16, 2016 20:30 pm UTC| Business
Enhanced ADCC activity of FPA144 may play an important mechanistic role in anti-tumor efficacy in cancers with modest expression of FGFR2b.FPA144 may reprogram the tumor micro-environment to create synergistic anti-tumor...